Catalyst
Slingshot members are tracking this event:
Aduro Biotech (ADRO) expects to submit an IND filing for antibody therapy Anti-CTLA4 in the first half of 2018
- Source Link:
- https://seekingalpha.com/filing/3351398
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ADRO | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 27, 2018
Occurred Source:
https://www.prnewswire.com/news-releases/cstones-anti-ctla-4-antibody-cs1002-receives-ind-approval-in-china-300703022.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Anti-ctla-4, Ind Filing, Antibody Therapy
